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NC-ND license (http://creativecommoSummary Background/Objective: To investigate the factors associated with recurrence of
differentiated thyroid cancer in children. We combined the clinical and pathological features
to guide surgical treatment options, ensure efficacy, and reduce complications.
Methods: A prospective analysis of clinical data of 43 cases of pediatric differentiated thyroid
cancer from March 2008 to June 2014 admitted in our department, including 38 cases of papil-
lary cancers and five cases of follicular cancer; 40 cases were Stage I and three cases were
Stage II (Union for International Cancer Control [UICC] Tumor Node Metastasis classification
[TNM] staging). We performed the operations according to the condition of lesions and lymph
nodes. Operations included subtotal resection in 36 cases, total resection in seven cases. We
applied statistical methods to investigate the risk factors of recurrence and postoperative
complications.
Results: The pathologic lymph node metastasis rate was 67.44% (29/43): Area VI lymph nodes
metastases in 20 cases and Area III/IV or Area II/V lymph nodes metastases in nine cases. Post-
operative hypocalcemia symptoms were seen in three cases and hoarseness in three cases, for
a total rate of 13.95% (6/43). Until December 2015, patients were followed up from 1.5 years
to 8.7 years, with a median of 4.9 years. There were three cases of cervical lymph node recur-
rence, one case of local recurrence, and one case of lung metastasis, for a total recurrence
rate of 11.63% (5/43); all patients survived. Log-rank test of Kaplan-Meier curves and Cox step-
wise regression analysis showed that lesion number, extrathyroidal extension, and lymph nodes
metastases were the risk factors for postoperative recurrence; the relative risk values were,
respectively, 3.117, 2.816, and 4.628 (pZ 0.041, pZ 0.048, and pZ 0.031, respectively)
and the 95% confidence intervals (CI) were, respectively, 1.094w8.735, 1.046w7.932, and
1.189w10.205. However, the lesion excision approach was not a risk factor for postoperative
recurrence (pZ 0.107). The logistic stepwise regression model showed that lesion excisionfinancial interests exist.
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56 C. Wang et al.approach was a risk factor for postoperative hypocalcemia and hoarseness; the odds ratio
value was 2.537 (pZ 0.037) and the 95% CI was 1.034w6.983.
Conclusion: Pediatric differentiated thyroid cancer has a high metastatic rate to lymph nodes
and distant organs, but the total prognosis is good. Application of total resection cannot neces-
sarily reduce the relapse rate of pediatric differentiated thyroid cancer, but it may increase
the postoperative hypocalcemia and hoarseness. The authors propose strictly adhering to
various operation indicators, and carrying out various operations with a full understanding
of the local lesion and lymph nodes in order to reduce relapse and postoperative complica-
tions.
Copyright ª 2016, Asian Surgical Association. Published by Elsevier Taiwan LLC. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Pediatric thyroid cancer is rare, accounting for 2.4e9% of
epithelial origin solid tumors in children,1 but there is an
increasing trend in the occurrence of this cancer.2 The most
common pathologies of differentiated thyroid cancers are
papillary and follicular.3 Compared with adult thyroid
cancer, pediatric differentiated thyroid cancer has
different clinical features and there are different treat-
ment strategies, with a lower malignancy, slower progress,
longer course, and better prognosis. Currently, a multiple
combined surgical-based therapy for the treatment of pe-
diatric thyroid cancer is advocated, but the treatment
standard is still not fully integrated, as Chinese and foreign
approaches are not consistent. To find a better clinical
treatment strategy, the authors explore the risk factors of
postoperative recurrence and common complications in this
article.
2. Methods
2.1. General data
We investigated 43 cases of children with pathologically
confirmed differentiated thyroid carcinoma who were
admitted to our department from March 2008 to June 2014.
There were 19 males and 24 females, with a male to female
ratio of 1:1.26. Patients were aged from 5 years old to 14
years old, with a median age of 8.7 years. The disease
course was from 1 week to 3 months. The main complaints
were a cervical area tumor in 25 cases, cervical lympha-
denectasis in eight cases, or disease was determined by
physical examination or laboratory examinations in 10
cases. (Table 1). We experienced no cases of hoarseness or
difficulty breathing.
2.2. Preoperative examination
All cases underwent neck ultrasonography, thyroid func-
tion, systemic radionuclide scans, and other tests before
the operation. Ultrasonography showed lesion located in
the left lobe in 17 cases, the right lobe in 23 cases, bilateral
lobes in three cases, solitary nodules in 38 cases, multiple
nodules in five cases, nodules with calcification in 17 cases,and cervical lymphadenectasis in 29 cases. Thyroid function
tests showed that thyroid-stimulating hormone (TSH) was
increased in five cases and antithyroid peroxidase autoan-
tibody (TPoAb) was elevated in two cases, while the rest
were normal. An ultrasound-guided fine needle aspiration
biopsy was performed in 13 cases, including 11 cases of
thyroid cancer, one case where follicular cells were found,
and in one case a few atypical cells were identified and
could not be ruled out as cancer. A systemic radionuclide
scan revealed pulmonary nodules in three cases, which
were used with lung enhanced computed tomography (CT)
to confirm disease, but no bone metastasis was identified.2.3. Surgical approach and pathology
According to local lesions, lymph nodes, and intraoperative
frozen pathology samples, we selected the appropriate
lesion excision approach, including subtotal resection (re-
fers to the ipsilateral lobe þ isthmus þ contralateral par-
tial lobectomy) for 34 cases and total resection for nine
cases. The pathology included 38 cases of papillary cancer,
five of follicular cancer, and 29 cases of lymph node
metastasis. The total lymph node metastasis rate was
67.44%, and Area VI lymph node metastasis was seen in 20/
29 cases, accounting for 68.97% of lymph node metastasis
cases. Using the Union for International Cancer Control
(UICC) Tumor Node Metastasis classification (TNM) staging
(2002 Edition) we saw 40 cases with Stage I disease and
three cases with Stage II disease (Table 1).2.4. Postoperative follow-up, recurrence, and
complications
We used a combination of outpatient service and telephone
follow-up for the patients. All cases were followed up
successfully. Three cases of lung metastasis (UICC Stage II)
received 131I therapy after the total resection surgery, and
the lung lesions disappeared. All cases were reviewed with
neck ultrasonography, thyroid function, thyroglobulin, cal-
cium, and chest examination every 3 months for 2 years,
every 6 months from 2w5 years, then annually after 5
years. Conventional postoperative oral levothyroxine tab-
lets were used for TSH suppression therapy for 5 years and
the TSH levels were maintained below 0.2 mU/L. If a review
Table 1 Patient demographic data.
Demographic data n (%)
Patient sex
Male 19 (44.19)
Female 24 (55.81)
Patient age (y) ðxSDÞ 9.1  0.83
Disease course (mo) ðxSDÞ 1.2  0.49
Main complaint
Cervical area tumor 25 (58.14)
Cervical lymphadenectasis 8 (18.60)
Medical examination
(physical and ultrasonic)
10 (23.26)
Lesion location
Left lobe 17 (39.53)
Right lobe 23 (53.49)
Bilateral lobes 3 (6.98)
Lesion size
<2.0 cm 24 (55.81)
2.0w4.0 cm 19 (44.17)
Lesion number
Solitary nodule 38 (88.37)
Multiple nodules 5 (11.63)
Extrathyroidal extension
Occur 6 (13.95)
None 37 (86.05)
Pathologic type
Papillary 38 (88.37)
Follicular 5 (11.63)
Tumor stage
Stage I 40 (93.02)
Stage II 3 (6.98)
Lesion excision
Subtotal resection 34 (79.07)
Total resection 9 (16.28)
Lymph node metastasis
None 14 (32.56)
Area VI 20 (46.51)
Area III/IV or II/V 9 (20.93)
Postoperative 131I therapy
Occur 8 (18.60)
None 35 (81.40)
SDZ standard deviation. Table 2 Log-rank test of Kaplan-Meier curves and Cox
regression analysis of postoperative recurrent data.
Characteristics Log-rank test Cox regression analysis
p RR (95% CI) p
Lesion location 0.318 d d
Lesion size 0.206 d d
Lesion number 0.029* 3.117 (1.094w8.735) 0.041
Extrathyroidal
extension
0.040* 2.816 (1.046w7.932) 0.048
Pathologic type 0.190 d d
Tumor stage 0.130 d d
Lesion excision 0.049* 1.169 (0.517w2.845) 0.107
Lymph node
metastasis
0.016* 4.628 (1.189w10.205) 0.031
Postoperative 131
I therapy
0.252 d d
*: significant variables into cox regression model.
CIZ confidence interval; RRZ relative risk.
Recurrence of pediatric thyroid cancer 57displayed a suspicion of recurrence or metastasis, oral
levothyroxine tablets were stopped for 2 weeks until the
TSH level increased before systemic radionuclide scans and
fine needle aspiration biopsy were used to confirm. Follow-
up was continued until the end of December 2015, from 1.5
years to 8.7 years with a median of 4.9 years, and no deaths
occurred. There were a total of five cases of recurrence
with a recurrence rate of 11.63% (5/43); cervical lymph
node recurrence in three cases, local recurrence in one
case, and pulmonary metastasis and recurrence in one
case. The local recurrence and two cases of cervical lymph
node recurrence were treated with reoperation and post-
operative 131I therapy. One case of cervical lymph node
recurrence received 131I therapy because of undergoing
total resection in the first operation and his family’s un-
willingness to undergo another operation. The lung recur-
rence patient also received 131I therapy. The lungrecurrence patient improved after 131I therapy with the
pulmonary lesion becoming significantly reduced without
completely disappearing. Follow-up for 6 years in this pa-
tient showed that the lesion did not progress. The other
four cases were cured, with the lesions disappearing after
treatment, and follow-up found no evidence of recurrence.
Postoperative hypocalcemia and hoarseness both occurred
in three cases for a total rate of 13.95% (6/43). Following
treatment with calcium, Methycobal supplements and
acupuncture, the symptoms were relieved to varying
degrees.
2.5. Statistical methods
We used SPSS 19.0 statistical software (SPSS 19.0 version:
IBM Corporation, 1 New Orchard Road, Armonk, New York,
United States) for data analysis to investigate the influence
of factors such as lesion location, lesion size, lesion num-
ber, extrathyroidal extension, pathologic type, tumor
stage, lesion excision, lymph node metastasis, and post-
operative 131I therapy on the postoperative recurrence and
complication. A log-rank test of Kaplan-Meier curves was
used to filter variables and the Cox regression model was
used to identify risk factors of the postoperative recur-
rence. A logistic regression model was used to filter vari-
ables and identify risk factors of the postoperative
complication. A p value <0.05 was considered statistically
significant and relative risk or odds ratio values were
obtained.
3. Results
3.1. Risk factors of recurrence
A log-rank test of Kaplan-Meier curves showed that variables
such as lesion number, extrathyroidal extension, lesion
excision, and lymph node metastasis were significant vari-
ables (pZ 0.029, pZ 0.040, pZ 0.049, and pZ 0.016,
respectively). Then Cox regression analysis showed that
58 C. Wang et al.lesion number, extrathyroidal extension, and lymph
node metastasis were the risk factors for postoperative
recurrence; the relative risk values were 3.117, 2.816, and
4.628, respectively (pZ 0.041, pZ 0.048, and pZ 0.031,
respectively) and the 95% CI were 1.094w8.735,
1.046w7.932, and 1.189w10.205, respectively. However,
lesion excision approach was not a risk factor for post-
operative recurrence (pZ 0.107) (Table 2).
3.2. Risk factors for postoperative complications
Logistic regression analysis (univariate) showed that lesion
number and lesion excision approach were significant var-
iables (pZ 0.043 and pZ 0.015). Then, logistic regression
analysis (multivariate) showed that lesion excision
approach was the risk factor for postoperative hypocalce-
mia and hoarseness; the odds ratio value was 2.537
(pZ 0.037) and the 95% CI was 1.034w6.983 (Table 3).4. Discussion
Pediatric thyroid cancer is rarely seen in the clinic. At
present, the most recognized cause is exposure to radia-
tion.4 After the 1986 Chernobyl nuclear accident, the
incidence of thyroid cancer in children who were exposed
to radioactive fallout increased significantly, especially for
children under the age of 4 years.5 Studies have shown that
the RET/PTC3 gene rearrangement frequently occurred in
children after radiation exposure, and this gene rear-
rangement is the most common in pediatric thyroid papil-
lary cancer.6
The clinical features of thyroid cancer in children and
adults are different. The features of pediatric thyroid
cancer are mainly: (1) solid nodules are relatively common
but cystic or solid-cystic lesions have also been found; (2)
the pathologic type is mainly based on differentiated can-
cer, and papillary cancer (Figs. 1A and B) is the mostTable 3 Logistic regression analysis of postoperative hy-
pocalcemia and hoarseness data.
Characteristics Univariate Multivariate
p OR (95% CI) p
Lesion location 0.436 d
Lesion size 0.450 d
Lesion number 0.043* d
Extrathyroidal
extension
0.114 d
Pathologic type 0.271 d
Tumor stage 0.082 d
Lesion excision 0.015* 2.537 (1.034w6.983) 0.037
Lymph node
metastasis
0.183 d
Postoperative 131
I therapy
0.214 d
* Significant variables into multivariate logistic regression
model.
CIZ confidence interval; ORZ odds ratio.common, while follicular cancer (Figs. 1C and D) is rela-
tively less common than in adults, and undifferentiated
cancer is extremely rare; (3) compared with adults, the
invasion rate of pediatric thyroid cancer is higher and
lymph node and distant organ metastases are more com-
mon. According to the literature, the rate of lymph node
metastasis is about 60e80% and the rate of lung metastasis
is around 10%7; and (4) invasion and lymph nodes and
distant organ metastases in children are more common than
in adults, but their biological effects are moderate, pro-
gression is slow, and the final prognosis is good after active
treatment.8 In this study, 38 cases of pediatric thyroid
papillary cancer, five cases of follicular cancer, and no
medullary cancer or undifferentiated cancer were seen.
The rate of local lymph node metastasis was 67.44%,
including Area VI lymph nodes metastasis that accounted
for 68.97% of lymph node metastasis. There were also three
cases of lung metastasis. All patients were alive after
treatment with no deaths during follow up, and the results
of treatment were satisfactory.
At present, pediatric differentiated thyroid cancers are
mostly treated with surgical resection combined with 131I
treatment and TSH suppression treatment to form
comprehensive treatment strategies. Most oncologists
believe that external radiation therapy and chemotherapy
is ineffective and it is now used infrequently. Although most
agree with surgical treatment, the lesion excision and
lymphadenectomy approach is still controversial.
To predict the lesion excision approach, some oncolo-
gists advocate bilateral thyroidectomy with the main rea-
sons as follows: (1) the bilateral lobes of the thyroid are not
separate and are linked to each other into an organ; you
must remove the entire organ in order to reduce the cancer
relapse; (2) pediatric differentiated thyroid cancer has the
characteristics of multifocal lesions. Amarasinghe et al9
reported that the incidence of residual cancer may in-
crease up to 30% without total thyroidectomy; and (3) pe-
diatric differentiated thyroid cancer has the characteristics
of a high metastatic rate to lymph nodes and lung, and the
total thyroidectomy may create favorable conditions for
131I therapy after the operation. Most Chinese oncologists
advocate subtotal instead of total resection and the main
considerations are as follows: (1) children undergo growth
and development and a total thyroidectomy may cause
permanent thyroid or parathyroid dysfunction, affecting
growth and development, even threatening life; (2) a long-
term follow-up review shows that the difference in local
recurrence and distant organ metastatic rates between
subtotal resection and total resection are not significant10;
and (3) the total prognosis for pediatric differentiated
thyroid cancer is good.
In this study the log-rank test of Kaplan-Meier curves and
Cox stepwise regression analysis the author used showed
that lesion number, extrathyroidal extension, and lymph
node metastasis were the risk factors for the recurrence of
pediatric differentiated thyroid cancer without lesion
excision approach. We offer the following analysis as rea-
sons: (1) the study of pediatric differentiated thyroid can-
cer, of which papillary or follicular cancer are the most
common pathological types, show that its biological
behavior is better than this cancer in adults. There were no
undifferentiated tumors that relapsed easily in the study,
Figure 1 Thyroid papillary cancer in children. (A) gross specimen; (B) microscopic view; (C) gross specimen; and (D) microscopic
view.
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recurrence of this kind of thyroid cancer; (2) UICC staging
was used in the study and there is only Stage I or Stage II
papillary and follicular cancer in patients under the age of
45 years; no Stage III or Stage IV disease was seen. In this
study, distant organ metastasis mainly focuses on lung
without bone metastasis, and even in the presence of
distant lung metastasis, the treatment is still satisfactory.
So the tumor stage may also have little effect on the
recurrence of this kind of thyroid cancer in the study, but it
requires a larger sample size for further study; (3) for the
extrathyroidal extension, the authors recommend cleanly
cutting the tumor-infiltrating tissue under the naked eyes
as far as possible, since it is a risk factor for postoperative
recurrence. If the tumor- infiltrating tissue cannot be
completely removed, postoperative 131I therapy is neces-
sary for the removal of residual cancer; and (4) for the
lesion excision approach, although Hay et al11 suggested
that the local recurrence rate after total resection was
lower than after unilateral lobectomy for the children
with thyroid cancer (p < 0.05), the American Thyroid As-
sociation in 2006 made no clear provision for surgical
excision standards for children with differentiated thyroid
cancer. In addition, some oncologists believe that theinfluence of subtotal and total resection on the recurrence
was not significantly different,10 but there may be some
impact on postoperative complications and growth and
development.12 In this study, the results showed that
the relation between lesion excision approach and post-
operative recurrence was not strong (pZ 0.107), but it is a
risk factor for postoperative hypocalcemia and hoarseness
(pZ 0.037). In addition, as an important endocrine
organ in children, the entire thyroid function is not fully
understood; the ability of levothyroxine tablets to
completely replace the entire thyroid function or not after
total resection lacks a long-term follow-up study and
endocrine-related complications in children after total
resection are more common.12 Therefore, the authors
believe that the lesion excision approach should be based
on the specific condition of the lesion and we consider the
relevant literature as follows: (1) if the lesion lies in the
side of lobes without invasion, it is appropriate to apply
subtotal resection, but the contralateral lobe needs to be
carefully explored with a preoperative contralateral lobe
fine-needle biopsy or intraoperative frozen pathology; (2)
when contralateral lobe invasion or multiple lesions are
found, a total resection should be considered, since lesion
number was a risk factor for postoperative recurrence in
60 C. Wang et al.this study; (3) when lesions near the isthmus are found
without foreign invasion, a subtotal resection should be
considered; and (4) for the cases with distant organ me-
tastases, positive surgical options are appropriate, and a
total resection should be applied together with post-
operative 131I therapy to achieve a favorable efficacy.
The lymphadenectomy approach remains somewhat
controversial for many oncologists. Most suggest that for a
central section lymphadenectomy (Area VI), the main
consideration is that the incidence of pediatric differenti-
ated thyroid carcinoma lymph node metastasis is greater
than in adults.9 Hay et al11 have reported an incidence up
to 50w80%. The central section lymph nodes are the most
likely site and are mainly composed of the paratracheal,
pretracheal, and prelarynx lymph nodes. In this study, the
lymph node metastasis rate was 67.44%; the Area VI lymph
node metastasis accounted for 68.97% of the total lymph
node metastasis, therefore the authors believe that the
central section lymphadenectomy is necessary, even for
children with cN0, because while less than half of the
central section lymph node metastasis are discovered by
preoperative physical and imaging examination, a signifi-
cant number are not discovered. Since deep cervical lymph
nodes have a wide range that includes Area II, Area III, Area
IV, and Area V, etc., and the metastasis rate is relatively
lower than for the central section, it is currently contro-
versial to routinely perform lymphadenectomy for the deep
cervical lymph nodes. In this study, lymph node metastasis
was a risk factor for postoperative recurrence, so the au-
thors consistently advise applying lymphadenectomy for
deep cervical lymph nodes that are positive or suspect from
a preoperative ultrasonography, fine needle aspiration bi-
opsy, or intraoperative frozen pathology. A modified lym-
phadenectomy which is mainly based on the central section
should be recommended, both to reduce the rate of re-
sidual cancer in the lymph nodes to the maximum extent,
and to protect the neck function in children as far as
possible.
In summary, the use of total resection in an attempt to
significantly reduce the recurrence rate is still debatable,
but it may increase the postoperative hypocalcemia and
hoarseness. Pediatric differentiated thyroid cancer has
many clinical and biological characteristics that are
different from adult disease, the final prognosis is good,
and even with recurrence you can still achieve good resultsafter surgery or 131I therapy.13 Therefore, the authors
suggest considering the various surgical indications in the
growth and development of children to ensure efficacy and
reduce complications.
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